Navigation Links
Study Finds Treatment with Metreleptin Improved Diabetes and Lipid Control in Patients with Partial Lipodystrophy
Date:6/4/2011

al presentation today at ENDO 2011. Dr. Oral was instrumental in initiating the first studies to investigate the therapeutic utility of leptin replacement in lipodystrophy while she was working at the National Institutes of Health (NIH). She is currently the Medical Director of the University of Michigan Health System (UMHS) Bariatric Surgery Program and Director of the UMHS' Metabolism, Endocrinology and Diabetes (MEND) Obesity and Metabolic Disorder Program.

Dr. Oral's team will also be presenting a poster at ENDO 2011 entitled, "Treatment of Severe Lipodystrophy with Metreleptin in a Patient with Active Juvenile Dermatomyositis" on Sunday, June 5 at 1:30 p.m. ET.

Study Findings from Oral Presentation (OR07-3)

The findings of this study involve an analysis of nine patients with partial lipodystrophy who received metreleptin treatment for more than six months. At baseline, 89 percent were not achieving adequate glycemic control (A1C greater than or equal to 7 percent), and 89 percent had hypertriglyceridemia (triglycerides greater than or equal to 150 mg/dL). Metreleptin treatment resulted in a reduction in mean A1C from 8.1 percent at baseline to 6.8 percent at six months, which was sustained through 15 months. Additionally, at six months, patients who were taking insulin experienced an average reduction of 110 units in their total daily insulin dose. Similarly, mean triglyceride concentrations were reduced from 318 mg/dL at baseline to 169 mg/dL at 15 months.

Safety observations were generally consistent with those observed in other studies, with the most common adverse events being fatigue and nausea.

These results complement findings obtained in other studies which, collectively, provide evidence to help support the potential efficacy and safety of metreleptin across a range of rare, generalized and partial lipodystrophy syndromes.

About Lipodystrophy

Lipodystrophy syndromes are characterized by a
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Questions Ability of Radiology Benefit Managers to Lower Costs
2. A Recent Study by ITGs Majestic Market Research Indicates a Strong Launch for Gilenya in Spite of Its Time-Consuming Initiation Process
3. Israeli Facility Study Demonstrates MGuard™ Stent System Helps Prevent Distal Embolization
4. Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients
5. Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment
6. All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated
7. Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)
8. Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
9. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
10. U-M Study: Children Dependent on Long-Term Mechanical Ventilation Require Longer, More Expensive Hospital Care
11. Use of TIGR® Matrix Surgical Mesh in Multi-Center Randomized Controlled TRAM Flap Study Passes 20 Patient Mark and Wins Praise from Participating Surgeons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced a ... United States and Canada , ... The deal, worth up to $8.5 million over the next ... clinical validation and regulatory approval of Daktari,s HCV test. ... point-of-care instrument that can detect low levels of virus directly ...
(Date:8/31/2015)... , Aug. 31, 2015  On August 5, 2015, ... Oregon denied motions to dismiss securities ... GALE ) and certain of its directors. The class ... "pump and dump" scheme to artificially inflate Galena,s stock ... the stock price was inflated, sold massive amounts of ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... Mich., Oct. 19 Stryker Corporation (NYSE: SYK ... 2010 as follows: Third Quarter Highlights ... currency basis (6.9% as reported) to $1,768 million Orthopaedic ... as reported) MedSurg Equipment sales increased 16.3% on ...
... SCOTTSDALE, Ariz., Oct. 19 Matrixx Initiatives, Inc. (Nasdaq: ... financial results for the fiscal 2011 second quarter and six ... market closes on Monday, October 25, 2010. An earnings conference ... 26, 2010 at 11:00 AM ET. To access ...
Cached Medicine Technology:Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results 2
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Connectivity Kit is now available. With the Connectivity Kit, EasySampler data ... automated jacketed lab reactor control experiment, on a touchscreen platform. , EasySampler fully ...
(Date:9/1/2015)... Los Angeles, CA (PRWEB) , ... September 01, 2015 , ... ... performs and makes the massage robots more effective and humanlike than ever before. With ... massage chairs, the Ogawa Refresh and the Ogawa Active SuperTrac. , As in ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of natural peel ... Bright, Calm, and Clear. , Formulated with alpha hydroxy acids and natural ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... a next-generation customer communications archiving solution integrated with Alfresco‘s enterprise content management ... and helps organizations save millions of dollars in printing costs by digitizing ...
(Date:9/1/2015)... ... September 01, 2015 , ... Anthony J. Tantillo, Esq., Attorney from ... his third consecutive year in a row. Through nomination, research and strategic evaluation ... Born in Niagara Falls, New York, Tantillo is a Buffalo State College graduate of ...
Breaking Medicine News(10 mins):Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 2Health News:Introducing Next-Generation Archiving Solution PRO Archiver for Alfresco® 3
... BKD ) announced today that it plans to release ... Wednesday, May 6, 2009. The Company has also scheduled a ... at 10:00 AM ET. The conference call can be accessed ... (from outside of the U.S.) ten minutes prior to the scheduled ...
... 30 The American Academy of Dermatology (Academy) today ... and Drug Administration,s (FDA) announcement that a box warning ... products and a medication guide will be distributed to ... are FDA-approved for the treatment of frown lines between ...
... International Scholarly Journals, Web of Science Can Identify Highly ... Perspective in the Face of the Current Swine Flu ... eb of Science is the world,s ... journals and 130,000 academic conferences from around the globe ...
... The battle for beauty now goes wrinkle-to-wrinkle, as ... expected to begin their challenge to Botox(R) sometime within ... the U.S. aesthetics market is sure to spark heated ... also between medical professionals soon to be promoting one ...
... drugs to encourage red blood cell formation (erythropoiesis-stimulating agents) ... death and serious adverse events such as blood clots, ... . , While the relative increased risk of death ... in cancer patients this increase might translate into significant ...
... (Nasdaq: BLUD ), a global leader in ... today announced that access to its presentation at the ... Conference in New York, NY will be available via ... scheduled for Tuesday, May 12, 2009, at 12:40 p.m. ...
Cached Medicine News:Health News:Brookdale Announces First Quarter 2009 Release and Earnings Call 2Health News:American Academy of Dermatology Responds to FDA Decision Regarding Botulinum Toxin Products 2Health News:Thomson Reuters Web of Science(R) Provides Insights Into More than a Century of Influenza Research for Today's Health Professionals 2Health News:Thomson Reuters Web of Science(R) Provides Insights Into More than a Century of Influenza Research for Today's Health Professionals 3Health News:Thomson Reuters Web of Science(R) Provides Insights Into More than a Century of Influenza Research for Today's Health Professionals 4Health News:New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble 2Health News:New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble 3Health News:Drugs to combat anemia in cancer patients increase risk of death 2
... feature a 2 adjustable belt buckle. You adjust ... the Apron off your shoulders. And now theres ... the female anatomy. ,For additional back support try ... reduce pressure on the vertebrae and help "lift ...
... modular and flexible system that can record up to ... the comfort of their home. The recorder weighs less ... pouch. The alkaline batteries are in a separate compartment ... standard flash memory card. EEG data recording time can ...
... on over 20 years of experience ... for the Life Sciences, the Freedom ... and possibilities for expansion according to ... easy-to-use software, Freedom EVOware, each system ...
... PROVISION Surgical Helmet System from DePuy offers ... This system helps meet OSHA recommendations regarding ... while creating a new standard for comfort. ... to offer unequaled comfort, featuring a lightweight, ...
Medicine Products: